Fu H - Search Results

1

Prognostic and Predictive Value of O⁶-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.

Zhang J, Zhu Y, Wang Y, Fu Q, Xie H, Liu Z, Fu H, Cao Y, Xu J, Dai B. Zhang J, et al. Among authors: fu q, fu h. Ann Surg Oncol. 2018 Jan;25(1):342-348. doi: 10.1245/s10434-017-6145-3. Epub 2017 Nov 7. Ann Surg Oncol. 2018. PMID: 29116491

2

Total pelvic exenteration for locally advanced rectal carcinoma.

Liu SY, Wang YN, Zhu WQ, Gu WL, Fu H. Liu SY, et al. Among authors: fu h. Dis Colon Rectum. 1994 Feb;37(2):172-4. doi: 10.1007/BF02047542. Dis Colon Rectum. 1994. PMID: 8306839

3

Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.

Fu H, Liu Y, Xu L, Liu W, Fu Q, Liu H, Zhang W, Xu J. Fu H, et al. Among authors: fu q. Tumour Biol. 2015 Aug;36(8):5791-9. doi: 10.1007/s13277-015-3248-y. Epub 2015 Feb 26. Tumour Biol. 2015. PMID: 25716202

4

Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis.

Fu Q, Chang Y, An H, Fu H, Zhu Y, Xu L, Zhang W, Xu J. Fu Q, et al. Among authors: fu h. Br J Cancer. 2015 Dec 1;113(11):1581-9. doi: 10.1038/bjc.2015.379. Epub 2015 Nov 10. Br J Cancer. 2015. PMID: 26554658 Free PMC article.

5

IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.

Wang Z, Xu L, Chang Y, Zhou L, Fu H, Zhang W, Yang Y, Xu J. Wang Z, et al. Among authors: fu h. Tumour Biol. 2016 Aug;37(8):11127-34. doi: 10.1007/s13277-016-4879-3. Epub 2016 Mar 1. Tumour Biol. 2016. PMID: 26926076

6

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

Xie H, Zhu Y, An H, Wang H, Zhu Y, Fu H, Wang Z, Fu Q, Xu J, Ye D. Xie H, et al. Among authors: fu q, fu h. Oncotarget. 2016 May 31;7(22):32723-30. doi: 10.18632/oncotarget.8737. Oncotarget. 2016. PMID: 27092876 Free PMC article.

7

Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma.

Fu H, Liu Y, Xu L, Chang Y, Zhou L, Zhang W, Yang Y, Xu J. Fu H, et al. Medicine (Baltimore). 2016 Apr;95(17):e3225. doi: 10.1097/MD.0000000000003225. Medicine (Baltimore). 2016. PMID: 27124015 Free PMC article.

8

High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma.

Wang J, Liu Y, Yang Y, Xu Z, Zhang G, Liu Z, Fu H, Wang Z, Liu H, Xu J. Wang J, et al. Among authors: fu h. Oncotarget. 2016 Jul 5;7(27):41986-41995. doi: 10.18632/oncotarget.9749. Oncotarget. 2016. PMID: 27259255 Free PMC article.

9

Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.

Niu T, Liu Y, Zhang Y, Fu Q, Liu Z, Wang Z, Fu H, Xu J, Liu K. Niu T, et al. Among authors: fu q, fu h. Oncotarget. 2016 Aug 2;7(31):50017-50026. doi: 10.18632/oncotarget.10312. Oncotarget. 2016. PMID: 27374181 Free PMC article.

10

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.

Wang Z, Xie H, Zhou L, Liu Z, Fu H, Zhu Y, Xu L, Xu J. Wang Z, et al. Among authors: fu h. Oncotarget. 2016 Aug 9;7(32):51525-51534. doi: 10.18632/oncotarget.10492. Oncotarget. 2016. PMID: 27409666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,401 results

Search Page

Filters